Adaptive Biotechnologies Corp (ADPT) Peer Comparison

$25.47

$-0.97 (-3.67%)

As on 28-Aug-2026 13:37EDT

Market cap

$4,148 Mln

Revenue (TTM)

$308 Mln

P/E Ratio

--

P/B Ratio

28.4

Div. Yield

0 %

Edit

	Adaptive Biotechnologies Corp (ADPT)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Market cap ($ Mln)	4,148	17,326	16,614	13,400	12,305
Revenue ($ Mln)	308	2,782	1,054	2,436	670
Net Profit ($ Mln)	-63.85	491.50	755.85	860.62	-319.95
Net Margin (%)	-20.73	17.67	71.69	35.33	-47.79
RoE (%)	-35.32	110.09	--	42.98	-71.14
Price to Earnings	--	36.49	19.38	17.01	--
Price-To-Book	28.41	39.43	10.05	7.27	26.44

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Adaptive Biotechnologies Corp (ADPT)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Operating Revenue	308.08	2,782.29	1,054.37	2,435.92	669.50
Cost of Revenue	75.68	1,982.07	103.47	85.67	19.14
Gross Profit	205.62	760.62	588.53	2,236.43	829.45
Operating Expenses	269.86	216.81	841.45	1,378.74	895.93
Operating Profit (EBIT)	-37.46	583.40	109.45	971.51	-226.44
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	-64.01	598.92	101.11	1,035.47	-252.08
Provision for Tax	0.00	107.42	-654.74	174.84	20.05
Profit after Tax (Net Income)	-63.85	491.50	755.85	860.62	-319.95
Minority Interest	-0.02	0.00	0.00	0.00	-47.83
Consolidated Profit	0.00	0.00	0.00	0.00	0.00

Liabilities ($ Mln)

	Adaptive Biotechnologies Corp (ADPT)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Shareholder's Funds	142.91	433.86	1,435.90	1,843.76	465.53
Minority Interest	-0.02	0.00	0.00	0.00	-47.83
Non-Current Liabilities	402.30	187.89	384.48	288.55	1,362.63
Current Liabilities	87.71	1,435.43	464.70	361.93	283.35
Total Liabilities	512.74	1,975.47	1,302.02	2,844.42	1,385.30

Assets ($ Mln)

	Adaptive Biotechnologies Corp (ADPT)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Non-Current Assets	220.12	1,006.90	895.24	1,243.41	440.60
Current Assets	420.56	1,050.29	1,389.84	1,250.82	1,671.41
Total Assets	512.74	1,975.47	1,302.02	2,844.42	1,385.30
Total Debt*	410.50	120.10	449.89	165.93	864.07
Net Current Assets	0.00	-385.14	0.00	888.90	1,388.07

Cashflow ($ Mln)

	Adaptive Biotechnologies Corp (ADPT)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Cash From Operating Activities	-45.99	713.22	51.77	884.27	179.55
Cash Flow from Investing Activities	37.95	-31.14	-8.15	350.44	-129.29
Cash from Financing Activities	30.40	-860.39	34.89	-969.59	74.01
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	Adaptive Biotechnologies Corp (ADPT)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
ROCE (%)	-15.04	53.56	-30.01	32.82	-0.17
ROE (%)	-35.32	110.09	163.18	42.98	-71.14
ROA (%)	-7.74	15.64	26.53	29.32	-16.12
EBIT Margin (%)	-10.42	21.13	5.73	31.04	-0.77
Net Margin (%)	-20.73	17.67	71.69	35.33	-47.79
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

Growth Ratios

	Adaptive Biotechnologies Corp (ADPT)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Revenue Growth (%)	50.13	24.67	114.85	9.23	12.22
EBIT Growth (%)	72.17	18.70	136.39	-3.99	93.17
Net Profit Growth (%)	47.33	17.50	378.76	42.89	-115.58
EPS Growth (%)	49.53	26.84	353.27	50.42	-73.87
Book Value Growth (%)	-23.31	164.02	816.12	-0.70	-13.57

Valuation Ratios

	Adaptive Biotechnologies Corp (ADPT)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Price / Earnings	-41.80	36.06	-59.76	15.79	-2,869.63
Price / Book Value	11.37	35.44	-80.42	5.72	10.04
Dividend Yield (%)	--	--	--	--	--
EV/EBITDA	-85.12	28.08	-121.54	12.44	25.04
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	Adaptive Biotechnologies Corp (ADPT)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debt to Equity	0.00	0.00	0.00	0.00	1.77
Short term debt to equity ratio	0.06	0.00	0.05	0.00	0.09
Current Ratio	4.79	0.73	2.99	3.46	5.90
Quick Ratio	4.68	0.73	2.32	3.38	5.90
Interest Coverage	-4.56	--	1.62	--	-1.72

Operating Efficiency Ratios

	Adaptive Biotechnologies Corp (ADPT)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debtors to sales (%)	16.07	15.88	21.25	13.74	1.28
Asset Turnover	0.37	0.89	0.37	0.83	0.34
Receivable days	60.72	50.42	85.52	43.48	1.50
Inventory Days	46.73	--	1,056.70	96.17	--
Payable days	35.14	6.26	331.01	147.97	221.81
Cash Conversion Cycle	72.31	--	811.21	-8.32	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly